G1 Therapeutics, Inc. Annual Operating Margin in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
G1 Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2023.
  • G1 Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -65.1 %, a 12.9% increase year-over-year.
  • G1 Therapeutics, Inc. annual Operating Margin for 2023 was -47.9 %, a 82% increase from 2022.
  • G1 Therapeutics, Inc. annual Operating Margin for 2022 was -265 %, a 41.3% increase from 2021.
  • G1 Therapeutics, Inc. annual Operating Margin for 2021 was -453 %, a 112% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -47.9 +218 +82% Jan 1, 2023 Dec 31, 2023
2022 -265 +187 +41.3% Jan 1, 2022 Dec 31, 2022
2021 -453 -240 -112% Jan 1, 2021 Dec 31, 2021
2020 -213 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.